Clever Leaves Holdings Inc. Stock

Equities

CLVR

CA1867602031

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-04-19 pm EDT 5-day change 1st Jan Change
4.081 USD -0.35% Intraday chart for Clever Leaves Holdings Inc. -9.92% +94.83%
Sales 2022 17.8 Sales 2023 17.42 Capitalization 3.66M
Net income 2022 -66M Net income 2023 -17M EV / Sales 2022 445,103 x
Net cash position 2022 8.59M Net cash position 2023 4.74M EV / Sales 2023 -62,512 x
P/E ratio 2022
-0.18 x
P/E ratio 2023
-0.18 x
Employees 296
Yield 2022 *
-
Yield 2023
-
Free-Float 87.61%
More Fundamentals * Assessed data
Dynamic Chart
Clever Leaves Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Clever Leaves Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Earnings Flash (CLVR) CLEVER LEAVES Reports Q4 Revenue $4.6M MT
An unknown buyer acquired Portuguese farm assets of Clever Leaves Holdings Inc. for $1.5 million. CI
KAC Investments LLC acquired Herbal Brands, Inc. from Clever Leaves Holdings Inc. for $8 million. CI
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia CI
Transcript : Clever Leaves Holdings Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (CLVR) CLEVER LEAVES Reports Q3 Revenue $3.8M, vs. Street Est of $5.2M MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Clever Leaves Holdings Inc. Revises Revenue Guidance for the Full Year 2023 CI
Transcript : Clever Leaves Holdings Inc., Q2 2023 Earnings Call, Aug 14, 2023
Earnings Flash (CLVR) CLEVER LEAVES Reports Q2 Revenue $5M, vs. Street Est of $5M MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Clever Leaves Holdings Inc. Reiterates Earnings Guidance for the Year 2023 CI
Clever Leaf Holdings Inc. Announces Colombian Flower Is Now Available to Australian Patients Through Strategic Partnership with Australian Natural Therapeutics Group CI
More news
1 day-0.88%
1 week-10.40%
Current month-16.65%
1 month+4.08%
3 months+44.45%
6 months+47.87%
Current year+93.79%
More quotes
1 week
4.03
Extreme 4.03
4.89
1 month
3.47
Extreme 3.47
5.89
Current year
2.00
Extreme 2.0022
5.89
1 year
1.72
Extreme 1.7158
10.20
3 years
1.72
Extreme 1.7158
372.00
5 years
1.72
Extreme 1.7158
583.81
10 years
1.72
Extreme 1.7158
583.81
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 18-12-31
Director of Finance/CFO 52 21-02-21
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 54 20-12-17
Director/Board Member 69 20-12-17
Chairman 54 22-01-31
More insiders
Date Price Change Volume
24-04-19 4.081 -0.35% 6 086
24-04-18 4.095 -3.19% 11,292
24-04-17 4.23 -6.84% 9,000
24-04-16 4.54 -2.04% 10,220
24-04-15 4.635 +2.32% 4,858

Delayed Quote Nasdaq, April 19, 2024 at 11:36 am EDT

More quotes
Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.095
Average target price
-
Consensus